Clinical research: sleep loss and inflammatory markers
Effect of sleep loss on C-Reactive protein, an inflammatory marker of cardiovascular risk

https://doi.org/10.1016/j.jacc.2003.07.050Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

We sought to investigate the effects of sleep loss on high-sensitivity C-reactive protein (CRP) levels.

Background

Concentrations of high-sensitivity CRP are predictive of future cardiovascular morbidity. In epidemiologic studies, short sleep duration and sleep complaints have also been associated with increased cardiovascular morbidity. Two studies were undertaken to examine the effect of acute total and short-term partial sleep deprivation on concentrations of high-sensitivity CRP in healthy human subjects.

Methods

In Experiment 1, 10 healthy adult subjects stayed awake for 88 continuous hours. Samples of high-sensitivity CRP were collected every 90 min for 5 consecutive days, encompassing the vigil. In Experiment 2, 10 subjects were randomly assigned to either 8.2 h (control) or 4.2 h (partial sleep deprivation) of nighttime sleep for 10 consecutive days. Hourly samples of high-sensitivity CRP were taken during a baseline night and on day 10 of the study protocol.

Results

The CRP concentrations increased during both total and partial sleep deprivation conditions, but remained stable in the control condition. Systolic blood pressure increased across deprivation in Experiment 1, and heart rate increased in Experiment 2.

Conclusions

Both acute total and short-term partial sleep deprivation resulted in elevated high-sensitivity CRP concentrations, a stable marker of inflammation that has been shown to be predictive of cardiovascular morbidity. We propose that sleep loss may be one of the ways that inflammatory processes are activated and contribute to the association of sleep complaints, short sleep duration, and cardiovascular morbidity observed in epidemiologic surveys.

Abbreviations

ANOVA
analysis of variance
BP
blood pressure
GCRC
General Clinical Research Center
HR
heart rate
CRP
C-reactive protein
IL
interleukin
PSD
partial sleep deprivation
TSD
total sleep deprivation

Cited by (0)

Experiment 1 was funded by two awards to Dr. Dinges from the Air Force Office of Scientific Research (F49620-1-0388 and F49620-00-1-0266). Experiment 2 was funded by two awards made by the NASA cooperative agreement NCC 9-58 with the National Space Biomedical Research Institute (to Drs. Dinges and Mullington). Support in carrying out this work was provided by National Institutes of Health, Bethesda, Maryland, grant MH-60641 to Dr. Mullington and grants NR04281, K23AG8672, and M01-RR00040 to Dr. Dinges. Dr. Ridker is listed as a co-inventor on patents that relate to the use of inflammatory biomarkers in cardiovascular disease (patents filed by the Brigham and Women's Hospital, Boston, Massachusetts).